NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2023
Back to search
Official data from USPTO
MARINUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/05/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/23/2021
Registration date
12/05/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2023
Last transaction
12/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/15/2023
First use in commerce
09/15/2023
Drawing code
3
Owner type
03
Owner location
Radnor, PA, US
Examiner
HILLIARD, JESSICA
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three non-concentric overlapping circles of different sizes to the left of the stylized word "MARINUS".
Holders and representatives
Holders
Marinus Pharmaceuticals, Inc.
Representatives
Keith Barritt FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of seizures and epilepsystatus epilepticusepileptic encephalopathiesencephalopathiesseizuresgenetic seizure disordersmovement disordersneurologic conditionsneurodegenerative diseasecerebrovascular diseasetraumatic brain injurysubstance abusesubstance withdrawaldementiadeliriumschizophreniabipolar disorderpsychosispsychiatric conditionsdepression
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/03/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/02/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/16/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/10/2023
IUAF
USE AMENDMENT FILED
09/28/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/25/2023
EX1G
SOU EXTENSION 1 GRANTED
01/23/2023
EXT1
SOU EXTENSION 1 FILED
01/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2022
PUBO
PUBLISHED FOR OPPOSITION
10/18/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/09/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/09/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/09/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/09/2022
DOCK
ASSIGNED TO EXAMINER
09/04/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2021
NWAP
NEW APPLICATION ENTERED
11/26/2021
Continuous trademark protection
Get notified about every new filing that threatens MARINUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.